Orchestra BioMed Holdings, Inc. (OBIO) Financials

OBIO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 115.7 million 86.3 million
March 31, 2026 100.7 million 49.7 million
Dec. 31, 2025 114.9 million 51.5 million
Sept. 30, 2025 104.8 million 61.1 million

OBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -19.6 million 2.5 million
March 31, 2026 -22.4 million 2.9 million
Dec. 31, 2025 -2.3 million 2.8 million
Sept. 30, 2025 -14.9 million 3.0 million

OBIO Net Income

No data available :(

OBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 110.0 million 20.4 million 1.3 million
March 31, 2026 94.4 million 32.1 million 730000
Dec. 31, 2025 106.5 million 30.8 million 936000
Sept. 30, 2025 95.8 million 14.2 million 1.8 million

OBIO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 63.8 million
March 31, 2026 62.7 million
Dec. 31, 2025 50.0 million
Sept. 30, 2025 52.2 million

OBIO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 254000 16.6 million 5.8 million -
March 31, 2026 184000 15.8 million 6.3 million -
Dec. 31, 2025 33000 16.8 million 7.3 million -
Sept. 30, 2025 310000 14.0 million 7.1 million -

OBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 88000 25000
March 31, 2026 110000 92000
Dec. 31, 2025 30.9 million 51000
Sept. 30, 2025 861000 49000

OBIO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

OBIO

Price: $5.47

52 week price:
2.20
5.66

Earnings Per Share: -0.84 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 265.1 million

Links: